The purification and identification of antioxidants and dipeptidyl peptidase IV inhibitory peptides from whey protein hydrolysates
Abstract
In the present study, whey protein was enzymatically hydrolyzed using an ultrahigh-pressure synergistic enzymolysis method. The antioxidant activities and DPP-IV inhibitory activities of the enzymatic hydrolysates were measured. Three-layer isolation and purification were conducted on the enzymatic hydrolysates with antioxidant activity and DPP-IV inhibitory activity by gel filtration chromatography and RP-HPLC. The amino acid sequences were determined by LC-MS/MS. The identified amino acid sequences were then synthesized, and their antioxidants and DPP-IV inhibitory activities were determined. The results showed that 3 of the 14 polypeptides of N3-8 exhibited high antioxidant activity. Among them, peptide DDQNPHSSN had both high antioxidant activity and DPP-IV inhibitory activity. When the concentration was 1 mg/mL, then the ABTS radical scavenging rate, DPPH radical scavenging rate and reducing power were prominent, reaching 91.42%, 88.76%, and 0.637%, respectively, and DPP-IV inhibitory activity reached 66.28%. Whey protease hydrolysates are expected to be commercially developed as functional peptides.
1 INTRODUCTION
Whey is a by-product produced during the production of cheese and casein. However, if whey is directly discharged into the environment without treatment, it will produce excessive pollution and cause serious environmental problems. On the other hand, since whey retains the nutrients found in raw milk, including protein, peptides, lipids, lactose, minerals, and vitamins, it has high nutritional value. Therefore, as a byproduct of production, whey is considered to have major development potential. At present, research studies have been conducted regarding whey reuse in many Western countries, and the utilization rate of whey in Europe has reached 80% (Argenta & Scheer, 2020; Nicolás et al., 2019; Zhao et al., 2017). However, in China, most whey has not been used due to the immature comprehensive utilization of whey. It has instead been directly discharged or returned to pasture-land for animal feed, which has resulted in resource waste and environmental pollution issues. Therefore, effective methods are urgently required to further strengthen the comprehensive utilization of whey, and large-scale production processes need to be quickly developed to solve the current waste and pollution problems.
Whey protein is one of the main components of whey. It has high nutritional value and functional characteristics. Whey protein has been widely used in various foods and is an ideal source of bioactive peptides. It has also been used to prepare bioactive peptides which have the effects of antioxidation; DPP-IV (dipeptidyl peptidasem IV) inhibition; angiotensin converting enzyme (ACE) inhibition; antibacterial properties; lowering of cholesterol, and so on. Embiriekah et al. (2018) hydrolyzed whey protein with trypsin to obtain enzymatic hydrolysate with antioxidant activities. Ballatore et al. (2020) obtained the peptides with high radical scavenging activity and cytoprotector effect by hydrolyzing WPC 35 with trypsin. Baba et al. (2021) identified peptides with potential anti-hypertensive properties from enzymatic hydrolysis of camel whey proteins. In another related study, Demers-Mathieu et al. (2013) hydrolyzed whey protein with trypsin and obtained enzyme hydrolysate with obvious antibacterial activities. In addition, Jiang et al. (2018) used a complex enzyme method to perform the enzymolysis of whey protein, and obtained the peptides with cholesterol lowering abilities through isolation and purification. Adjonu et al. (2013) treated whey protein with preheating treatments and protease hydrolysis to obtain doubly active peptides with antioxidant and ACE inhibitory abilities. Researchers (Mares-Mares et al., 2019; Nongonierma et al., 2017) obtained peptides displaying ACE inhibitory and DPP-IV inhibitory activities through the preparation of zymolytic whey protein. At present, the research regarding the preparation of peptides with double activities from whey proteins have generally focused on the combination of ACE inhibitory and DPP-IV inhibitory activities, as well as the combination of ACE inhibitory and antioxidant activities. However, only a few studies have concentrated on the preparation of peptides with antioxidant and DPP-IV inhibitory activities. Some of the previous studies (Corrochano et al., 2018; Jiang et al., 2019) have shown that, among the many proven bioactive peptides derived from whey protein, antioxidant activities are the most common. DPP-IV inhibitory activities effectively maintain the activity of incretin and prolong the action time of insulin. As a result, blood glucose levels can be more effectively regulated, which has become a new goal for the treatment of diabetes. Moreover, DPP-IV inhibitory peptides obtained from natural sources are currently hot topics in the development of oral hypoglycemic drugs. Therefore, effective methods of modifying whey protein to obtain peptides with both antioxidant and DPP-IV inhibitory activities have gradually attracted attention in this field.
The goals of the present study were to effectively isolate and purify whey protein hydrolysates with antioxidant and DPP-IV inhibitory activities to some extent, then to identify and synthesize the amino acid sequences of the obtained components. As a result, peptides with dual biological activities could then be obtained. Therefore, the findings of this study provided a relevant scientific basis for improving the deep processing of whey protein, as well as assisting in increasing the value and expanding the types of whey products.
2 MATERIALS AND METHODS
2.1 Materials and instruments
In the current study, the examined whey protein isolate (WPI, protein mass fraction 89%) was purchased from Müller Co.; trypsin and pepsin were purchased from Sigma (US); alkaline protease and papain were purchased from the Shanghai Yuanye Bio-Technology Co., Ltd; acid protease was purchased from Danisco; and all other reagents were analytical reagents.
An FPG7100 ultrahigh pressure instrument and an RT5 magnetic stirring apparatus were purchased from the IKA Co.; Molecular Devices (US) supplied a SepectraMax M5 microplate reader; a SPECORD-205 ultraviolet spectrophotometer was obtained from Analytikjena; Gene Vac (UK) provided the EZ-2 parallel evaporator; a Laborota 4000 rotary evaporator was acquired from Heidolph Co.; an AKTA + RID10A rapid purification chromatography system was supplied by General Electric Medical System Co., Ltd.; a Waters 2707 preparative liquid chromatograph was purchased from Waters Technologies Ltd.; and Agilent Technology Co., Ltd. provided an Agilent 1260 Infinity analytical liquid chromatograph.
2.2 Experiment method
2.2.1 Enzymatic hydrolysis of the whey protein isolates
This study referred to the methods used in previous studies (Pang et al., 2020) to prepare a 1% (w/v) WPI solution, which was treated for 30 min under 400 MPa ultra high-pressure conditions. Then, after adjusting the pH and temperature to the suitable conditions for pepsin, the solution was placed on a magnetic stirrer and pepsin was added to hydrolyze WPI for 60 min. Next, the pH and temperature were once again adjusted to the suitable conditions for acid protease, and acid protease was added to hydrolyze WPI for 60 min. The ratio of enzyme dosage of the pepsin and acid protease was 1:1. Following the completion of the hydrolysis to a predetermined time, the enzymes were terminated in boiling water for 10 min. Finally, after a cooling period, the supernatant was removed by centrifugation and lyophilized for future use.
2.2.2 Determination of antioxidant activities
The antioxidant activities of the WPI were evaluated by 2, 2-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid (ABTS) free radial scavenger activities; 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging activities, and total reducing power.
Determination of the ABTS free radical scavenging capacity
Determination of DPPH free radical scavenging capacity
Determination of total reducing power
The total reducing power of the sample was determined by referencing the method proposed by Yen and Duh (1993), in which 200 μl of the WPI sample was added to 0.5 ml of PBS (0.2 mol/L, pH 6.6) and 0.5 ml potassium ferricyanide (1%, w/v). Then, 5 ml of trichloroacetic acid (10%, w/v) was added following a 20 min reaction period at 50°C. Centrifugation was conducted for 10 min at 3000 rpm, and 0.5 ml of the supernatant was taken to mix with 0.5 ml of deionized water and 0.1 ml of ferric chloride (0.1%, w/v). Then, following a 10 min reaction period, the absorbance at 700 nm was determined. It was observed that the higher the absorbance, the stronger the reducing power.
2.2.3 Determination of DPP-IV activities
2.2.4 Isolation and purification of the bioactive peptides
Gel filtration chromatography
A protein purification system was used to conduct gel filtration chromatography of the samples. The separation conditions were as follows: The eluent was distilled water, with a flow rate of 1.0 ml/min and detection wavelength of 280 nm. According to the elution curve, the four components collected were separated and lyophilized using a vacuum freeze dryer. Next, the antioxidant and DPP-IV inhibitory activities of each component were determined, and the component with the highest biological activities was selected for further separation.
RP-HPLC separation
The components were further separated by RP-HPLC. The separation conditions were as follows: The chromatographic column was an XBridge C18; Mobile Phase A was ultra-pure water containing 0.1% trifluoroacetic acid (TFA); Mobile Phase B was acetonitrile solution containing 0.1% TFA; the injection volume was 500 μl; injection concentration was 50 mg/ml; flow rate was 1 ml/min; and detection wavelength was 280 nm. The elution conditions were 0–5 min at 100% A; 5–20 min at 100% A to 45% B; 20–30 min at 100% B; 31 min, stop. Each component was collected using an automatic collector, and the biological activities were determined after freeze-drying was completed.
LC-MS/MS identification
In the present study, the amino acid sequences of the components were identified by UPLC-MS/MS (Zhang et al., 2015). The chromatographic conditions were as follows: Mobile Phase A was ultrapure water containing 0.1% formic acid; Mobile Phase B was acetonitrile solution containing 0.1% formic acid; injection volume was 5 μl; injection mass concentration was 1 mg/ml; gradient elution condition was 0–63 min; and B was from 2% to 100%. An electrospray positive ion scanning mode was used, and the scanning range was between 0.2 and 2 ku. The two-stage MS collision voltage was 28 eV. The amino acid sequences of bovine species in the Swiss-Prot protein database were searched using PEAKS 10.0 software to obtain the amino acid sequences of the peptides. Peaks software was configured by setting the mass tolerances for precursor ions and fragment mass to 20 ppm and 0.2 Da, respectively (Xu et al., 2021). And the statistical approach of a False Discovery Rate was of less than 1% (Montandon et al., 2016).
2.2.5 Synthesis of the active peptides
The amino acid fragments of the peptides obtained by mass spectrometry were sent to a specialized biological company, and the peptides were synthesized using a solid-phase synthesis method. The peptides with purity levels higher than 90% were obtained by a cutting process and HPLC purification. The peptides were refrigerated at −20°C for future use.
2.3 Statistical analysis
All of this study's experimental processes were measured three times in parallel, and the data were expressed with the average value ± standard deviation. The drawings were completed using origin 8.0 software, then Excel and GraphPad prism 7.04 software were used for the statistical analysis of the data.
3 RESULTS AND DISCUSSION
3.1 Enzymatic hydrolysis conditions and biological activities of whey protein
The optimum conditions for enzymatic hydrolysis of the pepsin and acid protease are shown in Table 1. Under those conditions, the WPI was first hydrolyzed with pepsin for 60 min, then hydrolyzed with acid protease for 60 min. The antioxidant and DPP-IV inhibitory activities of the WPI were detected following the composite enzymatic hydrolysis of the WPI (Table 2). The results revealed that the enzymatic hydrolysate displayed both strong antioxidant and DPP-IV inhibitory activities. Therefore, this enzymatic hydrolysate was selected for the subsequent separation and purification processes.
Protease | Temperature (°C) | Time (min) | E/S(%) | pH |
---|---|---|---|---|
Pepsin | 40 | 60 | 1 | 2.5 |
Acid protease | 55 | 60 | 1 | 2.5 |
Indicator | DPPH inhibition rate (%) | ABTS inhibition rate (%) | Reducing power | DPP-IV inhibitory activity (%) |
---|---|---|---|---|
Untreated WPI | 12.29 ± 0.69b | 11.16 ± 0.68b | 0.141 ± 0.001b | 29.71 ± 0.63b |
Enzymatic hydrolysate | 62.97 ± 1.21a | 65.18 ± 1.06a | 0.399 ± 0.007a | 62.28 ± 0.65a |
- Note: In the table, the different lowercase letters indicate significant differences (p < 0.05).
- Abbreviations: ABTS, 2, 2-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid; DPP-IV, dipeptidyl peptidasem IV.
3.2 Gel filtration chromatography of the whey protein hydrolysates
The elution curves for the gel filtration chromatography of the WPI hydrolysates are detailed in Figure 1a. The following four components were isolated from the WPI hydrolysates using a gel filtration chromatography method.

As shown in Figure 1a, the four components separated by gel filtration chromatography were collected and their antioxidant and DPP-IV inhibitory activities were detected. The sample mass concentration was adjusted to 1 mg/ml. The antioxidant activities were measured by the indicator of ABTS free radical scavenging rate. The ABTS free radical scavenging rates are detailed in Figure 1b as follows: The ABTS free radical scavenging rate of Component N3 was significantly higher than those of the other components (p < 0.05), reaching 71.82 ± 1.09%. Figure 1c shows the DPP-IV inhibition rates of each component. The DPP-IV inhibition rates of Components N2 and N3 were determined to be 51.94 ± 0.69% and 52.43 ± 0.78%, respectively, which were significantly higher than those of Components N1 and N4 (p < 0.05). However, there were no significant differences observed between Components N2 and N3. Following this study's comprehensive comparison of the ABTS free radical scavenging rates and DPP-IV inhibition rates, Component N3 was selected for further separation processes following the gel filtration chromatography. However, there might be a single peptide with high antioxidant activity or high content of DPP-IV inhibitory enzyme in N1 and N2, which were worthy to further study.
3.3 Reversed-phase high-performance liquid chromatography (RP-HPLC) separation and purification of the N3 component
The chromatogram of Component N3 obtained by RP-HPLC separation is shown in Figure 1c. It can be seen in Figure 2a that Component N3 was divided into 13 different components through a C18 column, and the composition is relatively complex. Next, 13 components (N3-1 to N3-13) were collected. The concentration of the sample was adjusted to 1 mg/ml, and the antioxidant activities and DPP-IV inhibitory activities were determined.

Figure 2b shows that the ABTS free radical scavenging rate of Component N3-8 was the highest (82.96 ± 2.11%), and was significantly higher than that of the other components. Figure 2c shows that the DPP-IV inhibition rate of Component N3-7 was the highest (72.94 ± 1.95%), and was significantly higher than that of the other components. Therefore, in accordance with the comprehensive comparison detailed in Figure 2b and c, it was confirmed that Component N3-8 simultaneously displayed significant ABTS free radical scavenging and DPP-IV inhibition rates. Therefore, Component N3-8 was selected in this study for the subsequent mass spectrometry identification process.
3.4 Identification and analysis of the bioactive peptides derived from the whey protein by mass spectrometry
The amino acid sequence of the peptides in Component N3-8 was identified using LC-MS/MS. Following the identifications using mass spectrometry, 14 peptides were selected for this study's chemical synthesis process according to the relationships between the structures and the functions. In addition, the ABTS free radical scavenging and DPP-IV inhibitory activities of the synthetic peptides were detected. During the detection process, the detected mass concentration of the samples was set as 1 mg/ml.
In the present research investigation, three peptides (DDQNPHSSN, HLVDEPQNLIK and DDEVDVDGTVEEDLGK) with high-ABTS free radical scavenging activities were selected from Table 3, and their DPPH free radical scavenging rates and reducing powers were respectively determined at a sample mass concentration of 1 mg/ml (Table 4). The results indicated that the ABTS free radical scavenging rates, DPPH free radical scavenging rates, and reducing power of DDQNPHSSN were significant, reaching 91.42 ± 0.63%, 88.76 ± 0.41%, and 0.637 ± 0.016%, respectively. Previous studies have found that ultrahigh pressure can significantly change the surface morphology of WPI, change the content of α-helix, β-sheet and random coil of whey protein, and affect the secondary structure of protein. Therefore, it is speculated that the production of new active peptides is because ultrahigh pressure can expose the internal cleavage sites of proteins.
Peptide sequence | Protein source | Site | ABTS free radical scavenging rate (%) | DPP-IV inhibition rate (%) | |
---|---|---|---|---|---|
KIDALNENKVLVLD | β-lactoglobulin | 109 | 122 | 11.97 ± 0.73j | 21.33 ± 1.45h |
DDEVDVDGTVEEDLGK | Endoplasmin | 22 | 37 | 81.19 ± 1.04b | 48.69 ± 0.42de |
ELKDLKGY | α-lactalbumin | 30 | 37 | 56.24 ± 1.67d | 59.66 ± 0.33bc |
ETIKYLK | Glycosylation dependent cell adhesion molecule | 135 | 141 | 41.66 ± 1.03f | 35.87 ± 0.62fg |
LDAQSAPLRVY | β-lactoglobulin | 48 | 58 | 65.48 ± 0.94c | 44.91 ± 0.64e |
HLVDEPQNLIK | Serum albumin | 402 | 412 | 83.63 ± 0.31b | 71.23 ± 0.92a |
APFPEVFGK | α-s1-casein | 41 | 49 | 27.23 ± 0.29h | 7.03 ± 0.65ij |
LEILLQK | β-lactoglobulin | 70 | 76 | 61.52 ± 0.18cd | 31.90 ± 0.28g |
LTKCEVFR | α-lactalbumin | 22 | 29 | 53.48 ± 061de | 8.99 ± 0.32ij |
DDQNPHSSN | α-lactalbumin | 82 | 90 | 91.42 ± 0.63a | 63.28 ± 0.37b |
ELQDKIHPF | β-casein | 59 | 67 | 13.81 ± 0.42j | 38.76 ± 0.51ef |
LSFNPTQLEEQCHI | β-lactoglobulin | 165 | 178 | 18.33 ± 1.29i | 12.48 ± 0.59i |
ALVSTLVPLA | Polymeric immunoglobulin receptor | 631 | 640 | 47.52 ± 1.45e | 53.24 ± 1.26cd |
ALCSEKLDQW | α-lactalbumin | 128 | 137 | 32.94 ± 0.89g | 45.70 ± 0.44e |
- Note: In the table, the different lowercase letters indicate significant differences (p < 0.05).
- Abbreviations: ABTS, 2, 2-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid; DPP-IV, dipeptidyl peptidasem IV.
Peptide sequence | ABTS free radical scavenging rate (%) | DPPH free radical scavenging rate (%) | Reducing power |
---|---|---|---|
DDEVDVDGTVEEDLGK | 81.19 ± 1.04b | 75.82 ± 1.16b | 0.486 ± 0.011b |
HLVDEPQNLIK | 83.63 ± 0.31b | 71.96 ± 0.84c | 0.519 ± 0.008b |
DDQNPHSSN | 91.42 ± 0.63a | 88.76 ± 0.41a | 0.637 ± 0.016a |
- Note: In the table, the different lowercase letters indicate significant differences (p < 0.05).
- Abbreviations: ABTS, 2, 2-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid; DPP-IV, dipeptidyl peptidasem IV.
The three peptides HLVDEPQNLIK, DDQNPHSSN, and ELKDLKGY were found to display high DPP-IV inhibitory activities, respectively reaching 71.23 ± 0.92%, 66.28 ± 0.37%, and 59.66 ± 0.33% at a sample mass concentration of 1 mg/ml. Then, in accordance with the results of this study's comprehensive comparison of the two types of activities of each peptide, it was found that the DDQNPHSSN peptides not only had strong antioxidant activities, but also had displayed DPP-IV inhibitory activities with a certain intensity. Finally, the antioxidant and DPP-IV inhibitory activities of the DDQNPHSSN were determined once again. It was observed that the antioxidant activities were expressed by the Trolox equivalent (TE) and the DPP-IV inhibitory activities were expressed by the IC50 value. The ABTS free radical scavenging activities of the DDQNPHSSN were 121 ± 2.48 μmol TE/g protein; the DPPH free radical scavenging activities were 92 ± 2.67 μmol TE/g protein; and the total reducing power was 34 ± 1.56 μmol TE/g protein. The IC50 of the DDQNPHSSN was determined to be 79 ± 1.18 μmol/L. The amino acid sequence of the DDQNPHSSN was obtained using a mass spectrometry analysis method, as detailed in Figure 3.

4 CONCLUSIONS
In the present study, whey protein hydrolysate which was obtained by the enzymolysis of pepsin and acid protease displayed the dual biological activities of antioxidant activities and DPP-IV inhibitory activities. The whey protein hydrolysate was isolated and purified, and the amino acid sequence of Component N3-8 was determined using LC-MS/MS. Then, 14 peptides were selected for the synthesis and detection of their biological activities. The results revealed that the peptide DDQNPHSSN had displayed both high antioxidant activities and high DPP-IV inhibitory activities. It was found that at a concentration of 1 mg/mL, the ABTS free radical scavenging rates, DPPH free radical scavenging rates, and reducing power of the DDQNPHSSN peptide were 91.42%, 88.76%, and 0.637%, respectively, and the DPP-IV inhibitory activities were 66.28%. The results obtained in this study provided strong theoretical support for the deep development of whey powder, particularly the utilization of whey protein, and provided a scientific basis for expanding the varieties of whey products in the future.
AUTHOR CONTRIBUTIONS
Yuanrong Zheng: Writing−original draft; writing−review and editing. Jiakun Pang: Writing−review and editing. Zhenmin Liu: Writing−review and editing.
ACKNOWLEDGMENTS
This study was supported by National Key Research and Development Program of a study of the specificity of whey protein hydrolysis and the development of specific functional dairy products (2018YFC1604205) and Shanghai Dairy Bioengineering Technology Research Center (19DZ2281400).
CONFLICTS OF INTEREST
The authors declare no conflicts of interest.
ETHICS STATEMENT
None declared.